share_log

Jefferies Maintains Buy on GSK, Raises Price Target to $53

Jefferies Maintains Buy on GSK, Raises Price Target to $53

傑富瑞維持對GSK的買入評級,將目標價上調至53美元。
Benzinga ·  07/02 13:58

Jefferies analyst Peter Welford maintains GSK (NYSE:GSK) with a Buy and raises the price target from $52.5 to $53.

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論